Global and China Shingles Treatments Market Size, Status and Forecast 2020-2026
SKU ID :QYR-16356829 | Published Date: 02-Sep-2020 | No. of pages: 96Description
TOC
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Shingles Treatments Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Oral
1.2.3 Tablets
1.3 Market by Application
1.3.1 Global Shingles Treatments Market Share by Application: 2020 VS 2026
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Diagnostic Centres
1.3.5 Home Care Settings
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Shingles Treatments Market Perspective (2015-2026)
2.2 Global Shingles Treatments Growth Trends by Regions
2.2.1 Shingles Treatments Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Shingles Treatments Historic Market Share by Regions (2015-2020)
2.2.3 Shingles Treatments Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Shingles Treatments Players by Market Size
3.1.1 Global Top Shingles Treatments Players by Revenue (2015-2020)
3.1.2 Global Shingles Treatments Revenue Market Share by Players (2015-2020)
3.2 Global Shingles Treatments Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Shingles Treatments Revenue
3.4 Global Shingles Treatments Market Concentration Ratio
3.4.1 Global Shingles Treatments Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Shingles Treatments Revenue in 2019
3.5 Key Players Shingles Treatments Area Served
3.6 Key Players Shingles Treatments Product Solution and Service
3.7 Date of Enter into Shingles Treatments Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Shingles Treatments Breakdown Data by Type (2015-2026)
4.1 Global Shingles Treatments Historic Market Size by Type (2015-2020)
4.2 Global Shingles Treatments Forecasted Market Size by Type (2021-2026)
5 Shingles Treatments Breakdown Data by Application (2015-2026)
5.1 Global Shingles Treatments Historic Market Size by Application (2015-2020)
5.2 Global Shingles Treatments Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Shingles Treatments Market Size (2015-2026)
6.2 North America Shingles Treatments Market Size by Type (2015-2020)
6.3 North America Shingles Treatments Market Size by Application (2015-2020)
6.4 North America Shingles Treatments Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Shingles Treatments Market Size (2015-2026)
7.2 Europe Shingles Treatments Market Size by Type (2015-2020)
7.3 Europe Shingles Treatments Market Size by Application (2015-2020)
7.4 Europe Shingles Treatments Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Shingles Treatments Market Size (2015-2026)
8.2 China Shingles Treatments Market Size by Type (2015-2020)
8.3 China Shingles Treatments Market Size by Application (2015-2020)
8.4 China Shingles Treatments Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Shingles Treatments Market Size (2015-2026)
9.2 Japan Shingles Treatments Market Size by Type (2015-2020)
9.3 Japan Shingles Treatments Market Size by Application (2015-2020)
9.4 Japan Shingles Treatments Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Shingles Treatments Market Size (2015-2026)
10.2 Southeast Asia Shingles Treatments Market Size by Type (2015-2020)
10.3 Southeast Asia Shingles Treatments Market Size by Application (2015-2020)
10.4 Southeast Asia Shingles Treatments Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Astellas Pharma
11.1.1 Astellas Pharma Company Details
11.1.2 Astellas Pharma Business Overview
11.1.3 Astellas Pharma Shingles Treatments Introduction
11.1.4 Astellas Pharma Revenue in Shingles Treatments Business (2015-2020))
11.1.5 Astellas Pharma Recent Development
11.2 Foamix
11.2.1 Foamix Company Details
11.2.2 Foamix Business Overview
11.2.3 Foamix Shingles Treatments Introduction
11.2.4 Foamix Revenue in Shingles Treatments Business (2015-2020)
11.2.5 Foamix Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Shingles Treatments Introduction
11.3.4 Novartis Revenue in Shingles Treatments Business (2015-2020)
11.3.5 Novartis Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Shingles Treatments Introduction
11.4.4 Roche Revenue in Shingles Treatments Business (2015-2020)
11.4.5 Roche Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Shingles Treatments Introduction
11.5.4 GlaxoSmithKline Revenue in Shingles Treatments Business (2015-2020)
11.5.5 GlaxoSmithKline Recent Development
11.6 Epiphany Biosciences
11.6.1 Epiphany Biosciences Company Details
11.6.2 Epiphany Biosciences Business Overview
11.6.3 Epiphany Biosciences Shingles Treatments Introduction
11.6.4 Epiphany Biosciences Revenue in Shingles Treatments Business (2015-2020)
11.6.5 Epiphany Biosciences Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Shingles Treatments Introduction
11.7.4 Merck Revenue in Shingles Treatments Business (2015-2020)
11.7.5 Merck Recent Development
11.8 Beijing Minhai Biotechnology
11.8.1 Beijing Minhai Biotechnology Company Details
11.8.2 Beijing Minhai Biotechnology Business Overview
11.8.3 Beijing Minhai Biotechnology Shingles Treatments Introduction
11.8.4 Beijing Minhai Biotechnology Revenue in Shingles Treatments Business (2015-2020)
11.8.5 Beijing Minhai Biotechnology Recent Development
11.9 GeneOne Life Science
11.9.1 GeneOne Life Science Company Details
11.9.2 GeneOne Life Science Business Overview
11.9.3 GeneOne Life Science Shingles Treatments Introduction
11.9.4 GeneOne Life Science Revenue in Shingles Treatments Business (2015-2020)
11.9.5 GeneOne Life Science Recent Development
11.10 NAL Pharmaceuticals
11.10.1 NAL Pharmaceuticals Company Details
11.10.2 NAL Pharmaceuticals Business Overview
11.10.3 NAL Pharmaceuticals Shingles Treatments Introduction
11.10.4 NAL Pharmaceuticals Revenue in Shingles Treatments Business (2015-2020)
11.10.5 NAL Pharmaceuticals Recent Development
11.11 TSRL
10.11.1 TSRL Company Details
10.11.2 TSRL Business Overview
10.11.3 TSRL Shingles Treatments Introduction
10.11.4 TSRL Revenue in Shingles Treatments Business (2015-2020)
10.11.5 TSRL Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Tables & Figures
List of Tables
Table 1. Global Shingles Treatments Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Oral
Table 4. Key Players of Tablets
Table 5. Global Shingles Treatments Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 6. Global Shingles Treatments Market Size by Regions (US$ Million): 2020 VS 2026
Table 7. Global Shingles Treatments Market Size by Regions (2015-2020) (US$ Million)
Table 8. Global Shingles Treatments Market Share by Regions (2015-2020)
Table 9. Global Shingles Treatments Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 10. Global Shingles Treatments Market Share by Regions (2021-2026)
Table 11. Shingles Treatments Market Market Trends
Table 12. Shingles Treatments Market Drivers
Table 13. Shingles Treatments Market Challenges
Table 14. Shingles Treatments Market Restraints
Table 15. Global Shingles Treatments Revenue by Players (2015-2020) (US$ Million)
Table 16. Global Shingles Treatments Market Share by Players (2015-2020)
Table 17. Global Top Shingles Treatments Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Shingles Treatments as of 2019)
Table 18. Global Shingles Treatments by Players Market Concentration Ratio (CR5 and HHI)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Shingles Treatments Product Solution and Service
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global Shingles Treatments Market Size by Type (2015-2020) (US$ Million)
Table 23. Global Shingles Treatments Market Size Share by Type (2015-2020)
Table 24. Global Shingles Treatments Revenue Market Share by Type (2021-2026)
Table 25. Global Shingles Treatments Market Size Share by Application (2015-2020)
Table 26. Global Shingles Treatments Market Size by Application (2015-2020) (US$ Million)
Table 27. Global Shingles Treatments Market Size Share by Application (2021-2026)
Table 28. North America Shingles Treatments Market Size by Type (2015-2020) (US$ Million)
Table 29. North America Shingles Treatments Market Share by Type (2015-2020)
Table 30. North America Shingles Treatments Market Size by Application (2015-2020) (US$ Million)
Table 31. North America Shingles Treatments Market Share by Application (2015-2020)
Table 32. North America Shingles Treatments Market Size by Country (US$ Million) (2015-2020)
Table 33. North America Shingles Treatments Market Share by Country (2015-2020)
Table 34. Europe Shingles Treatments Market Size by Type (2015-2020) (US$ Million)
Table 35. Europe Shingles Treatments Market Share by Type (2015-2020)
Table 36. Europe Shingles Treatments Market Size by Application (2015-2020) (US$ Million)
Table 37. Europe Shingles Treatments Market Share by Application (2015-2020)
Table 38. Europe Shingles Treatments Market Size by Country (US$ Million) (2015-2020)
Table 39. Europe Shingles Treatments Market Share by Country (2015-2020)
Table 40. China Shingles Treatments Market Size by Type (2015-2020) (US$ Million)
Table 41. China Shingles Treatments Market Share by Type (2015-2020)
Table 42. China Shingles Treatments Market Size by Application (2015-2020) (US$ Million)
Table 43. China Shingles Treatments Market Share by Application (2015-2020)
Table 44. China Shingles Treatments Market Size by Region (US$ Million) (2015-2020)
Table 45. China Shingles Treatments Market Share by Region (2015-2020)
Table 46. Japan Shingles Treatments Market Size by Type (2015-2020) (US$ Million)
Table 47. Japan Shingles Treatments Market Share by Type (2015-2020)
Table 48. Japan Shingles Treatments Market Size by Application (2015-2020) (US$ Million)
Table 49. Japan Shingles Treatments Market Share by Application (2015-2020)
Table 50. Japan Shingles Treatments Market Size by Country (US$ Million) (2015-2020)
Table 51. Japan Shingles Treatments Market Share by Country (2015-2020)
Table 52. Southeast Asia Shingles Treatments Market Size by Type (2015-2020) (US$ Million)
Table 53. Southeast Asia Shingles Treatments Market Share by Type (2015-2020)
Table 54. Southeast Asia Shingles Treatments Market Size by Application (2015-2020) (US$ Million)
Table 55. Southeast Asia Shingles Treatments Market Share by Application (2015-2020)
Table 56. Southeast Asia Shingles Treatments Market Size by Country (US$ Million) (2015-2020)
Table 57. Southeast Asia Shingles Treatments Market Share by Country (2015-2020)
Table 58. Astellas Pharma Company Details
Table 59. Astellas Pharma Business Overview
Table 60. Astellas Pharma Product
Table 61. Astellas Pharma Revenue in Shingles Treatments Business (2015-2020) (US$ Million)
Table 62. Astellas Pharma Recent Development
Table 63. Foamix Company Details
Table 64. Foamix Business Overview
Table 65. Foamix Product
Table 66. Foamix Revenue in Shingles Treatments Business (2015-2020) (US$ Million)
Table 67. Foamix Recent Development
Table 68. Novartis Company Details
Table 69. Novartis Business Overview
Table 70. Novartis Product
Table 71. Novartis Revenue in Shingles Treatments Business (2015-2020) (US$ Million)
Table 72. Novartis Recent Development
Table 73. Roche Company Details
Table 74. Roche Business Overview
Table 75. Roche Product
Table 76. Roche Revenue in Shingles Treatments Business (2015-2020) (US$ Million)
Table 77. Roche Recent Development
Table 78. GlaxoSmithKline Company Details
Table 79. GlaxoSmithKline Business Overview
Table 80. GlaxoSmithKline Product
Table 81. GlaxoSmithKline Revenue in Shingles Treatments Business (2015-2020) (US$ Million)
Table 82. GlaxoSmithKline Recent Development
Table 83. Epiphany Biosciences Company Details
Table 84. Epiphany Biosciences Business Overview
Table 85. Epiphany Biosciences Product
Table 86. Epiphany Biosciences Revenue in Shingles Treatments Business (2015-2020) (US$ Million)
Table 87. Epiphany Biosciences Recent Development
Table 88. Merck Company Details
Table 89. Merck Business Overview
Table 90. Merck Product
Table 91. Merck Revenue in Shingles Treatments Business (2015-2020) (US$ Million)
Table 92. Merck Recent Development
Table 93. Beijing Minhai Biotechnology Business Overview
Table 94. Beijing Minhai Biotechnology Product
Table 95. Beijing Minhai Biotechnology Company Details
Table 96. Beijing Minhai Biotechnology Revenue in Shingles Treatments Business (2015-2020) (US$ Million)
Table 97. Beijing Minhai Biotechnology Recent Development
Table 98. GeneOne Life Science Company Details
Table 99. GeneOne Life Science Business Overview
Table 100. GeneOne Life Science Product
Table 101. GeneOne Life Science Revenue in Shingles Treatments Business (2015-2020) (US$ Million)
Table 102. GeneOne Life Science Recent Development
Table 103. NAL Pharmaceuticals Company Details
Table 104. NAL Pharmaceuticals Business Overview
Table 105. NAL Pharmaceuticals Product
Table 106. NAL Pharmaceuticals Revenue in Shingles Treatments Business (2015-2020) (US$ Million)
Table 107. NAL Pharmaceuticals Recent Development
Table 108. TSRL Company Details
Table 109. TSRL Business Overview
Table 110. TSRL Product
Table 111. TSRL Revenue in Shingles Treatments Business (2015-2020) (US$ Million)
Table 112. TSRL Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Shingles Treatments Market Share by Type: 2020 VS 2026
Figure 2. Oral Features
Figure 3. Tablets Features
Figure 4. Global Shingles Treatments Market Share by Application: 2020 VS 2026
Figure 5. Clinics Case Studies
Figure 6. Hospitals Case Studies
Figure 7. Diagnostic Centres Case Studies
Figure 8. Home Care Settings Case Studies
Figure 9. Shingles Treatments Report Years Considered
Figure 10. Global Shingles Treatments Market Size (US$ Million), YoY Growth 2015-2026
Figure 11. Global Shingles Treatments Market Share by Regions: 2020 VS 2026
Figure 12. Global Shingles Treatments Market Share by Regions (2021-2026)
Figure 13. Global Shingles Treatments Market Share by Players in 2019
Figure 14. Global Top Shingles Treatments Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Shingles Treatments as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Shingles Treatments Revenue in 2019
Figure 16. North America Shingles Treatments Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. United States Shingles Treatments Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Canada Shingles Treatments Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Europe Shingles Treatments Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Germany Shingles Treatments Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. France Shingles Treatments Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. U.K. Shingles Treatments Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Italy Shingles Treatments Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Russia Shingles Treatments Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Nordic Shingles Treatments Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Rest of Europe Shingles Treatments Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Asia-Pacific Shingles Treatments Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. China Shingles Treatments Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Japan Shingles Treatments Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. South Korea Shingles Treatments Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Southeast Asia Shingles Treatments Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. India Shingles Treatments Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Australia Shingles Treatments Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Rest of Asia-Pacific Shingles Treatments Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Latin America Shingles Treatments Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Mexico Shingles Treatments Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Brazil Shingles Treatments Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Middle East & Africa Shingles Treatments Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Turkey Shingles Treatments Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Saudi Arabia Shingles Treatments Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. UAE Shingles Treatments Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Rest of Middle East & Africa Shingles Treatments Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Astellas Pharma Revenue Growth Rate in Shingles Treatments Business (2015-2020)
Figure 44. Foamix Revenue Growth Rate in Shingles Treatments Business (2015-2020)
Figure 45. Novartis Revenue Growth Rate in Shingles Treatments Business (2015-2020)
Figure 46. Roche Revenue Growth Rate in Shingles Treatments Business (2015-2020)
Figure 47. GlaxoSmithKline Revenue Growth Rate in Shingles Treatments Business (2015-2020)
Figure 48. Epiphany Biosciences Revenue Growth Rate in Shingles Treatments Business (2015-2020)
Figure 49. Merck Revenue Growth Rate in Shingles Treatments Business (2015-2020)
Figure 50. Beijing Minhai Biotechnology Revenue Growth Rate in Shingles Treatments Business (2015-2020)
Figure 51. GeneOne Life Science Revenue Growth Rate in Shingles Treatments Business (2015-2020)
Figure 52. NAL Pharmaceuticals Revenue Growth Rate in Shingles Treatments Business (2015-2020)
Figure 53. TSRL Revenue Growth Rate in Shingles Treatments Business (2015-2020)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Companies
Astellas Pharma
Foamix
Novartis
Roche
GlaxoSmithKline
Epiphany Biosciences
Merck
Beijing Minhai Biotechnology
GeneOne Life Science
NAL Pharmaceuticals
TSRL
- PRICE
-
$3900$7800$5850Buy Now